Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Dig Dis Sci

Retrieve available abstracts of 70 articles:
HTML format

Single Articles

    July 2022
  1. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    PubMed     Abstract available

  2. FANG HW, Yen YH, Hung CH, Wang JH, et al
    Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir.
    Dig Dis Sci. 2022;67:3402-3411.
    PubMed     Abstract available

    June 2022
  3. BERNSTEIN DE, Trinh HN, Schiff ER, Smith CI, et al
    Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.
    Dig Dis Sci. 2022;67:2637-2645.
    PubMed     Abstract available

    May 2022
  4. LLOYD C, Leighton J, Wong LL, Goulding A, et al
    Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07525.
    PubMed     Abstract available

  5. CLARK PJ, Valery PC, Strasser SI, Weltman M, et al
    Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
    Dig Dis Sci. 2022 May 13. pii: 10.1007/s10620-022-07483.
    PubMed     Abstract available

  6. RAO A, Rule JA, Cerro-Chiang G, Stravitz RT, et al
    Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America.
    Dig Dis Sci. 2022 May 11. pii: 10.1007/s10620-022-07524.
    PubMed     Abstract available

  7. SHROFF H, Fix OK
    Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: Real or Imagined?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07509.

    April 2022
  8. CHOW KW, Pham NV, Ibrahim BM, Hong K, et al
    Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature.
    Dig Dis Sci. 2022 Apr 29. pii: 10.1007/s10620-022-07504.
    PubMed     Abstract available

  9. JONES E, Watkins M, Anderson E, Gelow K, et al
    Overlooked Symptoms in Autoimmune Hepatitis Negatively Impact Many Facets of Life.
    Dig Dis Sci. 2022 Apr 19. pii: 10.1007/s10620-022-07484.
    PubMed     Abstract available

    March 2022
  10. ANIEMEKA C, Pillai AA
    HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.

  11. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    PubMed     Abstract available

  12. MAK LY, Wong DK, Cheung KS, Hui RW, et al
    Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
    Dig Dis Sci. 2022 Mar 8. pii: 10.1007/s10620-022-07429.
    PubMed     Abstract available

  13. SAAB S, Pham N, Wu W, Dang L, et al
    Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naive Chronic Hepatitis B Patients.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07402.
    PubMed     Abstract available

    February 2022
  14. CZAJA AJ
    Advancing Biologic Therapy for Refractory Autoimmune Hepatitis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-021-07378.
    PubMed     Abstract available

    January 2022
  15. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    PubMed     Abstract available

    November 2021
  16. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    PubMed     Abstract available

    September 2021
  17. CHUN HS, Lee JS, Lee HW, Kim BK, et al
    Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2021 Sep 2. pii: 10.1007/s10620-021-07157.
    PubMed     Abstract available

    July 2021
  18. VAZ K, Little R, Majeed A, Kemp W, et al
    Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07140.
    PubMed     Abstract available

  19. TOKA B, Koksal AS, Eminler AT, Tozlu M, et al
    Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation.
    Dig Dis Sci. 2021;66:2417-2426.
    PubMed     Abstract available

    June 2021
  20. GELOW K, Chalasani S, Green K, Lammert C, et al
    Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.
    Dig Dis Sci. 2021 Jun 23. pii: 10.1007/s10620-021-07112.
    PubMed     Abstract available

    May 2021
  21. CHEN J, Hubbard A, Bagley L, Shiau R, et al
    Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 May 30. pii: 10.1007/s10620-021-07056.
    PubMed     Abstract available

  22. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available

  23. LIN MH, Li HQ, Zhu L, Su HY, et al
    Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
    PubMed     Abstract available

  24. HE WQ, Matthews GV, Liu B
    Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-07008.
    PubMed     Abstract available

    April 2021
  25. LAMMERT C, Chalasani SN, Green K, Atkinson E, et al
    Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.
    Dig Dis Sci. 2021 Apr 30. pii: 10.1007/s10620-021-06989.
    PubMed     Abstract available

  26. CZAJA AJ
    Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
    Dig Dis Sci. 2021 Apr 9. pii: 10.1007/s10620-021-06968.
    PubMed     Abstract available

  27. CHANG PE, Tan CK, Cheah CC, Li W, et al
    Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2021;66:1343-1348.
    PubMed     Abstract available

    March 2021
  28. LE E, Chee G, Kwan M, Cheung R, et al
    Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment.
    Dig Dis Sci. 2021 Mar 26. pii: 10.1007/s10620-021-06941.
    PubMed     Abstract available

    February 2021
  29. KANG N, Chung JW, Jang ES, Jeong SH, et al
    Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
    Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
    PubMed     Abstract available

  30. JONES BE, Allegretti AS, Pose E, Mara KC, et al
    Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06864.
    PubMed     Abstract available

  31. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
    Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
    PubMed     Abstract available

  32. STERLING RK, King WC, Khalili M, Kleiner DE, et al
    Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06860.
    PubMed     Abstract available

  33. EVON DM, Kim HP, Edwards A, Carda-Auten J, et al
    "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C.
    Dig Dis Sci. 2021 Feb 2. pii: 10.1007/s10620-021-06829.
    PubMed     Abstract available

    January 2021
  34. KIM S, Yoo S, Lee JI, Kim S, et al
    Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance.
    Dig Dis Sci. 2021 Jan 30. pii: 10.1007/s10620-021-06845.
    PubMed     Abstract available

  35. HONG SW, Choi WM, Hwang HW, Kim DS, et al
    Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06745.
    PubMed     Abstract available

  36. KUO MH, Tseng CW, Lu MC, Tung CH, et al
    Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06725.
    PubMed     Abstract available

    October 2020
  37. ROCCO A, Compare D, Risitano AM, Sgamato C, et al
    Bone Marrow of Contention: A Rare Case of Recurrent Acute Hepatitis.
    Dig Dis Sci. 2020 Oct 22. pii: 10.1007/s10620-020-06670.
    PubMed     Abstract available

  38. SHAMSEDDEEN H, Madathanapalli A, Are VS, Shah VH, et al
    Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06632.
    PubMed     Abstract available

    September 2020
  39. PATEL YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, et al
    Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
    Dig Dis Sci. 2020 Sep 23. pii: 10.1007/s10620-020-06616.
    PubMed     Abstract available

  40. TERRAULT NA, Ghany MG
    Enhanced Screening for Hepatitis D in the USA: Overcoming the Delta Blues.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06584.

  41. WINTERS AC, Kabany ME, Choi G, Saab S, et al
    Acute Liver Failure During Pregnancy: Happy to Recover from Hep E.
    Dig Dis Sci. 2020;65:2515-2517.

    August 2020
  42. FERRE-ARACIL C, Riveiro-Barciela M, Trapero-Marugan M, Rodriguez-Peralvarez M, et al
    Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06569.
    PubMed     Abstract available

  43. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available

  44. HYUN HK, Cho EJ, Park SY, Hong YM, et al
    Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
    Dig Dis Sci. 2020 Aug 28. pii: 10.1007/s10620-020-06533.
    PubMed     Abstract available

  45. CZAJA AJ
    Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.
    Dig Dis Sci. 2020 Aug 24. pii: 10.1007/s10620-020-06562.
    PubMed     Abstract available

  46. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
    High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
    Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
    PubMed     Abstract available

    July 2020
  47. CHANG ML, Hu JH, Chen WT, Lin MS, et al
    Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels.
    Dig Dis Sci. 2020 Jul 31. pii: 10.1007/s10620-020-06507.
    PubMed     Abstract available

  48. OHFUJI S, Matsuura T, Tamori A, Kubo S, et al
    Lifestyles Associated with Prognosis After Eradication of Hepatitis C Virus: A Prospective Cohort Study in Japan.
    Dig Dis Sci. 2020 Jul 27. pii: 10.1007/s10620-020-06475.
    PubMed     Abstract available

  49. BENHAMMOU JN, Moon AM, Pisegna JR, Su F, et al
    Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C.
    Dig Dis Sci. 2020 Jul 11. pii: 10.1007/s10620-020-06457.
    PubMed     Abstract available

  50. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
    Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
    PubMed     Abstract available

    June 2020
  51. BEN MERABET Y, Barbe C, Heurgue-Berlot A, Thevenot T, et al
    Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.
    Dig Dis Sci. 2020 Jun 30. pii: 10.1007/s10620-020-06444.
    PubMed     Abstract available

  52. SHIN JW, Jeong J, Jung SW, Lee SB, et al
    Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Dig Dis Sci. 2020 Jun 10. pii: 10.1007/s10620-020-06375.
    PubMed     Abstract available

    May 2020
  53. MCNALLY BB, Carey EJ
    Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06347.
    PubMed     Abstract available

  54. DOSHI SD, Stotts MJ, Hubbard RA, Goldberg DS, et al
    The Changing Burden of Alcoholic Hepatitis: Rising Incidence and Associations with Age, Gender, Race, and Geography.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06346.
    PubMed     Abstract available

  55. HUYNH T, Hu KQ
    Excellent Safety and Sustained Virologic Response to Direct-Acting Antivirals Treatment in HCV-Infected Geriatric Patients: A Real-World Data.
    Dig Dis Sci. 2020 May 13. pii: 10.1007/s10620-020-06286.
    PubMed     Abstract available

  56. YUEN MF, Liu SH, Seto WK, Mak LY, et al
    Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06281.
    PubMed     Abstract available

    April 2020
  57. OUZAN D, Larrey D, Guyader D, Remy AJ, et al
    Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
    Dig Dis Sci. 2020 Apr 18. pii: 10.1007/s10620-020-06234.
    PubMed     Abstract available

  58. CHAUHAN A, Kumar R, Sharma S, Mahanta M, et al
    Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study.
    Dig Dis Sci. 2020 Apr 11. pii: 10.1007/s10620-020-06246.
    PubMed     Abstract available

  59. CAREY W
    Know When to Hold 'em, Know When to Treat 'em, Know When to Cut 'em: Why Severe Alcoholic Hepatitis Is Becoming a Surgical Disease.
    Dig Dis Sci. 2020 Apr 8. pii: 10.1007/s10620-020-06239.

  60. O'BEIRNE J
    Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence.
    Dig Dis Sci. 2020 Apr 3. pii: 10.1007/s10620-020-06235.

  61. MUKHTAR NA, Evon DM, Yim C, Lok AS, et al
    Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06224.
    PubMed     Abstract available

    February 2020
  62. WONG K, Podboy A, Lavezo J, Goel A, et al
    Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis.
    Dig Dis Sci. 2020;65:399-400.

    January 2020
  63. YIK B, Shah N
    Autoconversion of Autoimmune Liver Diseases.
    Dig Dis Sci. 2020;65:71-73.

  64. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.

    November 2019
  65. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    PubMed     Abstract available

    October 2019
  66. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    PubMed     Abstract available

    August 2019
  67. SHERMAN KE, Abdel-Hameed EA, Ehman RL, Rouster SD, et al
    Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05815.
    PubMed     Abstract available

  68. SAYINER M, Stepanova M, De Avila L, Golabi P, et al
    Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Dig Dis Sci. 2019 Aug 27. pii: 10.1007/s10620-019-05786.
    PubMed     Abstract available

  69. WALLACE MC, Sek K, Francis RJ, Samuelson S, et al
    Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05781.
    PubMed     Abstract available

    June 2019
  70. SEMMLER G, Stift J, Scheiner B, Woran K, et al
    Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
    Dig Dis Sci. 2019 Jun 17. pii: 10.1007/s10620-019-05702.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.